Newly Diagnosed FLT3 Mutated AML
1 clinical trials · Condition
◉ Watch Newly Diagnosed FLT3 Mutated AML
| Record | Firm | Date |
|---|---|---|
| Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML (NCT03258931) | Arog Pharmaceuticals, Inc. | 2018-08-15 |
Track Newly Diagnosed FLT3 Mutated AML automatically
Every clearance here is in the API, with alerts when new ones post.